New York State Common Retirement Fund Has $688,000 Stake in Mesa Laboratories, Inc. (MLAB)

New York State Common Retirement Fund reduced its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 17.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 3,300 shares of the medical instruments supplier’s stock after selling 700 shares during the quarter. New York State Common Retirement Fund’s holdings in Mesa Laboratories were worth $688,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in the company. Conestoga Capital Advisors LLC grew its stake in shares of Mesa Laboratories by 2.3% in the 4th quarter. Conestoga Capital Advisors LLC now owns 486,256 shares of the medical instruments supplier’s stock valued at $101,331,000 after purchasing an additional 10,817 shares during the period. BlackRock Inc. grew its position in Mesa Laboratories by 8.8% during the 3rd quarter. BlackRock Inc. now owns 229,196 shares of the medical instruments supplier’s stock worth $42,542,000 after acquiring an additional 18,611 shares during the last quarter. Vanguard Group Inc grew its position in Mesa Laboratories by 2.1% during the 3rd quarter. Vanguard Group Inc now owns 161,627 shares of the medical instruments supplier’s stock worth $30,000,000 after acquiring an additional 3,309 shares during the last quarter. Vanguard Group Inc. grew its position in Mesa Laboratories by 2.1% during the 3rd quarter. Vanguard Group Inc. now owns 161,627 shares of the medical instruments supplier’s stock worth $30,000,000 after acquiring an additional 3,309 shares during the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC grew its position in Mesa Laboratories by 1.4% during the 4th quarter. Kayne Anderson Rudnick Investment Management LLC now owns 155,388 shares of the medical instruments supplier’s stock worth $32,382,000 after acquiring an additional 2,220 shares during the last quarter. Institutional investors own 76.33% of the company’s stock.

In other Mesa Laboratories news, Director David M. Kelly sold 2,000 shares of the company’s stock in a transaction on Wednesday, February 6th. The stock was sold at an average price of $229.62, for a total transaction of $459,240.00. Following the transaction, the director now owns 3,900 shares of the company’s stock, valued at approximately $895,518. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director John Bradley Schmieder sold 2,500 shares of the company’s stock in a transaction on Friday, February 8th. The stock was sold at an average price of $232.70, for a total value of $581,750.00. Following the transaction, the director now directly owns 75,939 shares in the company, valued at approximately $17,671,005.30. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 19,842 shares of company stock worth $4,607,649. Company insiders own 15.00% of the company’s stock.

NASDAQ MLAB opened at $228.89 on Tuesday. The company has a market cap of $891.69 million, a P/E ratio of 36.47 and a beta of 0.37. Mesa Laboratories, Inc. has a one year low of $138.54 and a one year high of $241.83. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.20 and a current ratio of 1.57.

Mesa Laboratories (NASDAQ:MLAB) last released its quarterly earnings results on Monday, February 4th. The medical instruments supplier reported $1.69 EPS for the quarter, topping the Zacks’ consensus estimate of $1.68 by $0.01. The business had revenue of $26.68 million for the quarter, compared to analyst estimates of $25.80 million. Mesa Laboratories had a return on equity of 23.53% and a net margin of 9.98%. Analysts forecast that Mesa Laboratories, Inc. will post 5.1 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Thursday, February 28th were given a dividend of $0.16 per share. The ex-dividend date of this dividend was Wednesday, February 27th. This represents a $0.64 dividend on an annualized basis and a yield of 0.28%. Mesa Laboratories’s dividend payout ratio (DPR) is presently 10.36%.

MLAB has been the topic of a number of research analyst reports. BidaskClub lowered Mesa Laboratories from a “buy” rating to a “hold” rating in a research report on Thursday, March 7th. TheStreet upgraded Mesa Laboratories from a “c” rating to a “b-” rating in a research report on Friday, February 8th. Zacks Investment Research upgraded Mesa Laboratories from a “hold” rating to a “buy” rating and set a $257.00 price target on the stock in a research report on Friday, February 8th. Finally, Sidoti initiated coverage on Mesa Laboratories in a research report on Wednesday, March 13th. They set a “neutral” rating on the stock. Three research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. Mesa Laboratories currently has a consensus rating of “Hold” and a consensus target price of $257.00.

COPYRIGHT VIOLATION WARNING: “New York State Common Retirement Fund Has $688,000 Stake in Mesa Laboratories, Inc. (MLAB)” was posted by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this story on another site, it was illegally copied and republished in violation of international copyright law. The correct version of this story can be accessed at https://sportsperspectives.com/2019/04/02/new-york-state-common-retirement-fund-has-688000-stake-in-mesa-laboratories-inc-mlab.html.

Mesa Laboratories Profile

Mesa Laboratories, Inc designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness.

Read More: Balance Sheet

Want to see what other hedge funds are holding MLAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mesa Laboratories, Inc. (NASDAQ:MLAB).

Institutional Ownership by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.